Loading...

Loading...

Clinical Innovation Only Counts If Accessible
By Cinthya Alaniz Salazar - Fri, 09/02/2022 - 13:32
To augment the ROI of clinical investment, public access needs to be fortified.
https://mexicobusiness.news/tag/bms
More Health
The Week in Health: New HIV Generic Coming to the Market
By Miriam Bello - Thu, 08/04/2022 - 10:00
The UN and GSK’s ViiV HealthCare plan to distribute a generic drug to prevent HIV. This and more in the weekly roundup.
BMS Welcomes New General Manager for Mexico
By Miriam Bello - Tue, 08/02/2022 - 12:23
Bristol Myers Squibb (BMS) appointed Oswaldo Bernal as its new General Manager in Mexico.
Immunotherapy: The Future of Healthcare
By Miriam Bello - Fri, 02/18/2022 - 13:41
Bristol Myers Squibb celebrates 75 years of research and innovation in Mexico with the introduction of new treatments.
Puebla has a New Medical Cluster
By Miriam Bello - Wed, 02/09/2022 - 14:17
Puebla roots its economic reactivation in health-oriented efforts. This and more in this week’s roundup!
Women in Healthcare: Their Experience as Industry Leaders
By Mónica López - Fri, 09/24/2021 - 17:47
Representation matters, here are the experiences of Latin Women leading the healthcare industry.
Women Share Their Experience as Healthcare Industry Leaders
By Miriam Bello - Thu, 09/09/2021 - 18:50
Representation matters, here are the experiences of Latin Women leading the healthcare industry.
Novel Drug Financing Models for Innovative Medicines
By Miriam Bello - Fri, 08/06/2021 - 16:02
Innovation in pharma relies on financing. However, traditional financing models have proven wanting in delivering the desired patient outcomes.
As R&D Costs Increase, the Industry Must Find Innovative Ways to Bring Them Down
By - Thu, 09/19/2019 - 17:52
R&D investment in life sciences continues unabated, leading to record-level pipelines for new medications.However,smaller returns on investment in R&D and a wave of patent expirations may dampen the steady growth of the global pharmaceutical industry